717ÒøÓéÓÅÔ½»á¿Í·þ

Ͷ×ÊÕß¹ØÏµ

INVESTOR RELATIONS

ÎÒ¹ú¿ÆÑ§¼Ò»ùÓÚÖÊÆ×Á÷ʽÊÖÒÕ¿ª·¢ÔçÆÚÖ×ÁöÕï¶ÏÒªÁì


ȪԴ£ºÖйúÉúÎïÊÖÒÕÉú³¤ÖÐÐÄ

 

¶ñÐÔÖ×ÁöÆð²¡ÒþÄ䣬ÔçÆÚÕï¶ÏÄѶȴó£¬ÏÖÔÚÁÙ´²Ê¹ÓõÄѪÇåѧ±ê¼ÇÎïѸËٶȼ°ÌØÒì¶ÈÈÔÓдýÌáÉý ¡£ÖÊÆ×Á÷ʽÊÖÒÕ£¨CyTOF£©×÷ΪÐÂÉú³¤ÆðÀ´µÄ¼ì²âÃâÒßϸ°û×é³ÉºÍÊýÄ¿µÄÊÖÒÕ£¬¿É»ñµÃÍâÖÜѪÃâÒßϸ°û×é³É¡¢±íÐͺ͹¦Ð§µÄ¸ßάÐÅÏ¢ ¡£Ê¹ÓÃÖÊÆ×Á÷ʽÊÖÒÕÆÀ¼ÛÍâÖÜÃâÒß״̬£¬ÓÐÍûΪÖ×ÁöÔçɸÔçÕïÌṩȫй¤¾ß ¡£

¿ËÈÕ£¬½ÒÏþÔÚ¡¶Gut¡·ÉÏÌâΪ“Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study”µÄÑо¿ÖУ¬Õã½­´óѧҽѧԺÁ¥ÊôµÚÒ»Ò½ÔºÑо¿Ö°Ô±»ùÓÚÖÊÆ×Á÷ʽ¼ì²âÍâÖÜѪϸ°û×é·Ö¸Ä±ä¹¹½¨Á˸ΰ©¡¢ÒÈÏÙ°©É¸²éÄ£×Ó£¬È¡µÃÁËÓÅÒìµÄÖ×ÁöÕï¶ÏЧÄÜ£¬ÓÐÍûÌá¸ßÏà¹ØÖ×ÁöÔçÕïÂÊ£¬½ø¶ø¸ÄÉÆÕⲿ·Ö»¼ÕßµÄÔ¤ºóÇéÐÎ ¡£

¸ÃÑо¿ÊÇÏÖÔÚ×î´ó¹æÄ£µÄ»ùÓÚÖÊÆ×Á÷ʽÊÖÒÕÆÀ¹ÀÍâÖÜÃâÒß²¢¿ª·¢Ö×ÁöÕï¶ÏÒªÁìµÄÑо¿£¬Ã÷È·ÁËÍâÖÜÃâÒßϸ°ûÑÇȺµÄ¸Ä±ä¿ÉÒÔ·´Ó¦Ö×Áö±¬·¢Éú³¤ÇéÐÎ ¡£ÕâÒ»ÒªÁìÓÐ×÷Ϊ·º°©ÔçɸÔçÕïµÄDZÄÜ£¬ÓÐÍûÔÚδÀ´¿µ½¡ÈËÌå¼ìºÍÖ×Áö¸ßΣÈËȺɸ²éÖÐʩչÖ÷Òª×÷Óà ¡£

 

 

×¢£º´ËÑо¿Ð§¹ûÕª×Ô¡¶Gut¡·£¬ÎÄÕÂÄÚÈݲ»´ú±í±¾ÍøÕ¾¿´·¨ºÍ̬¶È£¬½ö¹©²Î¿¼ ¡£

 

ÍøÕ¾µØÍ¼